About The Study: Modifiable risk factors are a major cause of ischemic heart disease in the U.S., with increasing contributions attributable to high body mass index and high fasting plasma glucose; addressing barriers to reducing risk exposure is essential to lessen ischemic heart disease mortality.
Corresponding Author: To contact the corresponding author, Gregory A. Roth, MD, email rothg@uw.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamacardio.2026.2435)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2026.2435?guestAccessKey=013f94b4-b91d-4e60-8ce5-d0bce752e318&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071526
Journal
JAMA Cardiology